Email Alert | RSS    帮助

中国防痨杂志 ›› 2019, Vol. 41 ›› Issue (5): 569-574.doi: 10.3969/j.issn.1000-6621.2019.05.018

• 短篇论著 • 上一篇    下一篇

经纤维支气管镜介入冷冻联合其他方法治疗气管支气管结核的疗效及不良反应分析

王志刚1(),刘媛媛2   

  1. 1 124000 辽宁省盘锦市传染病医院结核一科
    2 电子支气管镜室(刘媛媛);
  • 收稿日期:2019-01-14 出版日期:2019-05-10 发布日期:2019-05-10

Analysis of efficacy and adverse reactions of interventional cryotherapy via fiberoptic bronchoscope for endobronchial tuberculosis

Zhi-gang WANG1(),Yuan-yuan LIU2   

  1. 1 The First Department of Tuberculosis, Panjin Infectious Diseases Hospital, Liaoning Province, Panjin 124000, China
  • Received:2019-01-14 Online:2019-05-10 Published:2019-05-10

摘要:

目的 收集2015年5月至2018年6月辽宁省盘锦市传染病医院收治的全部64例溃疡坏死型和肉芽增殖型气管支气管结核患者。64例患者均进行了规范的抗结核药物治疗、雾化吸入、经纤维支气管镜(简称“纤支镜”)钳夹清创并局部灌注异烟肼注射液。其中,2017年3月及以前我院未开展纤支镜介入冷冻治疗,共收治患者31例,作为对照组;2017年4月及以后我院开展纤支镜介入冷冻治疗,共收治患者33例,作为观察组。观察两组患者痰菌阴转率、纤支镜下表现、临床症状、胸部CT扫描表现、气促指数、介入治疗次数及不良反应发生情况。观察组痰菌阴转率、临床治疗有效率、纤支镜下有效率、胸部CT检查有效率分别为96.8%(30/31)、97.0%(32/33)、93.9%(31/33)、90.9%(30/33),均明显高于对照组的65.5%(19/29)、74.2%(23/31)、64.5%(20/31)、67.7%(21/31),差异均有统计学意义(χ 2值分别为9.78、5.11、8.55、5.30,P值分别为0.002、0.024、0.003、0.021)。观察组介入治疗次数和治疗后气促指数的中位数(四分位数)[M(Q1,Q3)]分别为5(4,6)次和1(0,1)分,均明显少于对照组的9(8,10)次和2(1,2)分,差异均有统计学意义(Z值分别为6.05和3.37,P值均<0.001)。观察组不良反应发生率为24.2%(8/33),与对照组的25.8%(8/31)相比,差异无统计学意义(χ 2=0.02,P=0.885)。研究认为,经纤支镜介入冷冻治疗溃疡坏死型和肉芽增殖型气管支气管结核临床疗效明显,痰菌阴转率高,可减少治疗次数,且不增加不良反应发生率,是一种安全有效的治疗方法。

关键词: 纤维支气管镜, 支气管疾病, 结核, 冷冻疗法, 综合疗法, 疗效比较研究

Abstract:

Sixty-four cases of ulcerative necrotizing and granulation proliferative endobronchial tuberculosis were collected from May 2015 to June 2018 in Panjin Infectious Diseases Hospital. All patients were treated with standardized antituberculosis drugs, aerosol inhalation, debridement through fiberoptic bronchoscope, and local perfusion of isoniazid injection. Among them, 31 patients who were admitted in March 2017 or before and did not receive bronchoscopy interventional cryotherapy were included as control group, and 33 patients who were admitted in April 2017 and later and underwent interventional cryotherapy via fiberoptic bronchoscope were included as observation group. The sputum negative conversion rate, microscopic manifestations, clinical symptoms, chest CT findings, shortness of breath index, treatment times and adverse reactions were observed. The sputum negative conversion rate, clinical treatment efficiency, microscopic efficiency and imaging efficiency of the observation group were 96.8% (30/31), 97.0% (32/33), 93.9% (31/33) and 90.9% (30/33), respectively, which were significantly higher than those of the control group (65.5% (19/29), 74.2% (23/31), 64.5% (20/31) and 67.7% (21/31)), and the differences were statistically significant (χ 2 values were 9.78, 5.11, 8.55 and 5.30, P values were 0.002, 0.024, 0.003 and 0.021). The median number of interventions (quartile) (M(Q1,Q3)) and shortness of breath index after treatment in the observation group were 5 (4, 6) times and 1 (0, 1) scores, which were significantly lower than those in the control group (9 (8, 10) times and 2 (1, 2) scores), and the difference was statistically significant (Z values were 6.05 and 3.37, all P values <0.001). The incidence of adverse reactions in the observation group was 24.2% (8/33), compared with 25.8% (8/31) of the control group, there was no significant difference (χ 2=0.02, P=0.885). It is concluded that interventional cryotherapy with fiberoptic bronchoscope is a safe and effective treatment for ulcerative necrotizing and granulation proliferative endobronchial tuberculosis, with a high sputum negative conversion rate and a low incidence of adverse reactions.

Key words: Bronchoscopes, Bronchial diseases, Tuberculosis, Cryotherapy, Combined modality therapy, Comparative effectiveness research